gtag('config', 'AW-16657171524');

Starting August 1st, 2024, Eurobio Scientific is manufacturing and selling IVD kits for: EndoPredict® (Breast Cancer) / Prolaris® (Prostate Cancer) Read more

Clinical summaries

Download clinical summaries of the key studies for the EndoPredict® Breast Cancer Prognostic Test.

Clinical validation of EndoPredict in premenopausal women

Constantinidou et al. Clin. Cancer Res. 2022

Download
Prediction of chemotherapy benefit by EndoPredict

Sestak et al. Breast Cancer Res. Treat. 2019

Download
Prediction of 15-year distant recurrence with EndoPredict in node negative and positive patients

Filipits et al. Clin. Cancer Res. 2019

Download
Comparison of performance of 6 prognostic signatures for ER positive breast cancer

Sestak et al. JAMA Oncol. 2018

Download
Comparison of EndoPredict with Oncotype DX® for prediction of distant recurrence risk after endocrine therapy

Buus et al. J. Natl. Cancer Inst. 2016

Download